Literature DB >> 28199044

Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.

Nir Hirshoren1, Julia Danne1, Benjamin John Dixon1,2, Matthew Magarey1, Stephen Kleid1, Angela Webb1, Albert Tiong3, June Corry3, David Gyorki1,2.   

Abstract

BACKGROUND: The minority of head and neck cutaneous squamous cell carcinomas (SCC) metastasize to regional lymph nodes. The purpose of this study was to describe the clinical outcomes and prognostic factors for patients with node-positive head and neck cutaneous SCC who underwent lymphadenectomy.
METHODS: We conducted a retrospective single center study using the Kaplan-Meier method for the investigation of the overall survival (OS) and locoregional control rates. The Cox proportional hazards model was evaluated to identify prognostic factors.
RESULTS: The median number of positive lymph nodes from 149 lymphadenectomies was 2 in the neck and 1 in the parotid gland. The 5-year OS and locoregional control rates were 50% and 77%, respectively. OS was worse among older patients (hazard ratio [HR], 1.04; p = .015), immunosuppressed patients (HR, 2.06; p = .034), and patients with a high total lymph node ratio (calculated from the number of positive lymph nodes divided by the total number of nodes; multivariate analysis [MVA]; HR, 1.13; p = .019).
CONCLUSION: Low total lymph node ratio is associated with improved outcomes in node-positive head and neck cutaneous SCC.
© 2017 Wiley Periodicals, Inc. Head Neck 39: 772-778, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cutaneous squamous cell carcinoma; head and neck; lymph node ratio; prognostic parameters; radiation

Mesh:

Substances:

Year:  2017        PMID: 28199044     DOI: 10.1002/hed.24683

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  12 in total

Review 1.  Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Dai Ogata; Tetsuya Tsuchida
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

2.  Sentinel lymph node biopsy for head and neck cutaneous squamous cell carcinoma using the Brigham and Women's staging system: a cost analysis.

Authors:  Patrick L Quinn; Jin K Kim; Vishnu Prasath; Neal Panse; Thomas J Knackstedt; Ravi J Chokshi
Journal:  Arch Dermatol Res       Date:  2022-03-18       Impact factor: 3.017

3.  Outcomes of Cutaneous Squamous Cell Carcinoma in the Head and Neck Region With Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis.

Authors:  Axel Sahovaler; Rohin J Krishnan; David H Yeh; Qi Zhou; David Palma; Kevin Fung; John Yoo; Anthony Nichols; S Danielle MacNeil
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-04-01       Impact factor: 6.223

4.  Deep learning automated pathology in ex vivo microscopy.

Authors:  Marc Combalia; Sergio Garcia; Josep Malvehy; Susana Puig; Alba Guembe Mülberger; James Browning; Sandra Garcet; James G Krueger; Samantha R Lish; Rivka Lax; Jeannie Ren; Mary Stevenson; Nicole Doudican; John A Carucci; Manu Jain; Kevin White; Jaroslav Rakos; Daniel S Gareau
Journal:  Biomed Opt Express       Date:  2021-05-05       Impact factor: 3.562

5.  Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.

Authors:  Jaakko S Knuutila; Pilvi Riihilä; Samu Kurki; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Acta Derm Venereol       Date:  2020-09-23       Impact factor: 3.875

Review 6.  Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review.

Authors:  Joshua Lubov; Mathilde Labbé; Krystelle Sioufi; Grégoire B Morand; Michael P Hier; Manish Khanna; Khalil Sultanem; Alex M Mlynarek
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-09-07

7.  Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Guilherme Rabinowits; Michael R Migden; Todd E Schlesinger; Robert L Ferris; Morganna Freeman; Valerie Guild; Shlomo Koyfman; Anna C Pavlick; Neil Swanson; Gregory T Wolf; Scott M Dinehart
Journal:  JID Innov       Date:  2021-08-25

8.  TBC1D14 inhibits autophagy to suppress lymph node metastasis in head and neck squamous cell carcinoma by downregulating macrophage erythroblast attacher.

Authors:  Tao Lu; Yanshi Li; Min Pan; Dan Yu; Zhihai Wang; Chuan Liu; Guohua Hu
Journal:  Int J Biol Sci       Date:  2022-02-07       Impact factor: 6.580

9.  Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt.

Authors:  Stephanie Flukes; Sallie Long; Shivangi Lohia; Christopher A Barker; Lara A Dunn; Jennifer Cracchiolo; Ian Ganly; Snehal Patel; Marc A Cohen
Journal:  OTO Open       Date:  2021-01-08

10.  Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases.

Authors:  Alberto Grammatica; Michele Tomasoni; Milena Fior; Emanuela Ulaj; Tommaso Gualtieri; Paolo Bossi; Simonetta Battocchio; Davide Lombardi; Alberto Deganello; Davide Mattavelli; Piero Nicolai; Fabio Girardi; Cesare Piazza
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-25       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.